These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10445679)
1. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. Schwieler JH; Ericsson H; Löfdahl P; Thulin T; Kahan T J Cardiovasc Pharmacol; 1999 Aug; 34(2):268-74. PubMed ID: 10445679 [TBL] [Abstract][Full Text] [Related]
2. Clevidipine: a review of its use in the management of acute hypertension. Deeks ED; Keating GM; Keam SJ Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440 [TBL] [Abstract][Full Text] [Related]
3. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers. Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Ericsson H; Bredberg U; Eriksson U; Jolin-Mellgård A; Nordlander M; Regårdh CG Anesthesiology; 2000 Apr; 92(4):993-1001. PubMed ID: 10754618 [TBL] [Abstract][Full Text] [Related]
5. Clevidipine for controlled hypotension during spinal surgery in adolescents. Tobias JD Middle East J Anaesthesiol; 2011 Jun; 21(2):269-74. PubMed ID: 22435279 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension. Smith WB; Marbury TC; Komjathy SF; Sumeray MS; Williams GC; Hu MY; Mould DR Eur J Clin Pharmacol; 2012 Oct; 68(10):1385-94. PubMed ID: 22457015 [TBL] [Abstract][Full Text] [Related]
7. Clevidipine in adult cardiac surgical patients: a dose-finding study. Bailey JM; Lu W; Levy JH; Ramsay JG; Shore-Lesserson L; Prielipp RC; Brister NW; Roach GW; Jolin-Mellgard A; Nordlander M Anesthesiology; 2002 May; 96(5):1086-94. PubMed ID: 11981147 [TBL] [Abstract][Full Text] [Related]
8. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. Kieler-Jensen N; Jolin-Mellgård A; Nordlander M; Ricksten SE Acta Anaesthesiol Scand; 2000 Feb; 44(2):186-93. PubMed ID: 10695913 [TBL] [Abstract][Full Text] [Related]
9. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension. Kenyon KW Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. Nordlander M; Sjöquist PO; Ericsson H; Rydén L Cardiovasc Drug Rev; 2004; 22(3):227-50. PubMed ID: 15492770 [TBL] [Abstract][Full Text] [Related]
11. Clevidipine for the treatment of severe hypertension in adults. Nguyen HM; Ma K; Pham DQ Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue distribution of clevidipine and its metabolite in dogs and rats. Zhou Y; He XM; Li HQ; Ni Y; Xu MZ; Chen H; Li WY J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):856-860. PubMed ID: 25480581 [TBL] [Abstract][Full Text] [Related]
13. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. Ericsson H; Schwieler J; Lindmark BO; Löfdahl P; Thulin T; Regårdh CG Chirality; 2001; 13(3):130-4. PubMed ID: 11270321 [TBL] [Abstract][Full Text] [Related]
14. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Levy JH; Mancao MY; Gitter R; Kereiakes DJ; Grigore AM; Aronson S; Newman MF Anesth Analg; 2007 Oct; 105(4):918-25, table of contents. PubMed ID: 17898366 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Ericsson H; Fakt C; Höglund L; Jolin-Mellgård A; Nordlander M; Sunzel M; Regårdh CG Eur J Clin Pharmacol; 1999 Mar; 55(1):61-7. PubMed ID: 10206087 [TBL] [Abstract][Full Text] [Related]
17. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Singla N; Warltier DC; Gandhi SD; Lumb PD; Sladen RN; Aronson S; Newman MF; Corwin HL; Anesth Analg; 2008 Jul; 107(1):59-67. PubMed ID: 18635468 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs. Ericsson H; Tholander B; Björkman JA; Nordlander M; Regårdh CG Drug Metab Dispos; 1999 May; 27(5):558-64. PubMed ID: 10220482 [TBL] [Abstract][Full Text] [Related]
19. Clevidipine for acute hypertension in patients with subarachnoid hemorrhage: a pilot study. Varelas PN; Abdelhak T; Corry JJ; James E; Rehman MF; Schultz L; Mays-Wilson K; Mitsias P Int J Neurosci; 2014 Mar; 124(3):192-8. PubMed ID: 24007334 [TBL] [Abstract][Full Text] [Related]
20. Effect of clevidipine, an ultra-short acting 1,4-dihydropyridine calcium channel blocking drug, on the potency of isoflurane in rats and dogs. de Wolff MH; Leather HA; Wouters PF Eur J Anaesthesiol; 2000 Aug; 17(8):506-11. PubMed ID: 10998034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]